Black Rose Industries Ltd (BLACKROSE) is currently trading at 103.07 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Black Rose Industries is an integrated chemical manufacturer and distributor focused on acrylamide, N-methylol acrylamide (NMA) and polyacrylamide (liquid and powder), operating manufacturing sites in Jhagadia and distribution networks across India and select export markets, supported by a wholly-owned Japanese subsidiary, B.R. Chemicals Co. Ltd. The company reported a strong Q4 operating performance with revenue growth of 38% and EBITDA expansion of roughly 90%, attributing gains to its stock-and-sales distribution model, improved manufacturing volumes and better product mix while maintaining a debt-free balance sheet and declaring a 125% dividend. Black Rose is commercializing downstream products: PAM solid is in piloting with planned commercialization this year, acrylamide liquid and NMA volumes have grown, and the firm continues R&D at a new Navi Mumbai lab while progressing a Specialty Amines project with Koei Chemicals. Exports have been volatile due to geopolitical and tariff pressures—US oil & gas tariff policy reduced offtake—yet management highlights REACH and KKDIK registrations and participation in international exhibitions as tactical moves to regain and expand overseas market share. Operationally, the company exited lower-value ceramic binder operations, focused on upstream acrylamide and higher-value applications, and reported inventories moderation and market-share additions which supported margin expansion despite commodity price volatility.

Over the past 52 weeks, Black Rose Industries Ltd has traded between a low of ₹61.00 and a high of ₹130.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Black Rose Industries Ltd has a market capitalization of approximately 525.25. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Black Rose Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.12 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 525.25 Cr, Black Rose Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Black Rose Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Black Rose Industries Ltd is 15.12. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Black Rose Industries disclosed decisions dated 30 January 2025 and 14 August 2025 to discontinue B.R. Chemicals Co. Limited and begin its closure, sale or transfer. The filing does not state a commercial reason for the decision or explain why winding up was selected instead of a sale or transfer.

Black Rose Industries reported standalone net profit of Rs 10.49 crore for the quarter ended September 30, 2026. This compared with Rs 4.43 crore in the quarter ended September 30, 2025, and Rs 10.41 crore in the June 2026 quarter.

Black Rose Industries reported trade payables to creditors other than micro and small enterprises of Rs 46.74 crore at September 30, 2026, compared with Rs 24.94 crore at March 31. The filing does not state the commercial reason for the increase or identify suppliers, payment terms or products involved.

Black Rose is scheduled to consider and approve its unaudited Q2 FY27 and half-year FY27 results at its board meeting on November 6, 2026. The results cover the quarter and half year ended September 30, 2026.